🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these accounts directly for source information, while also receiving discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Sellers promote the substance there before directing customers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed medication in the UK is a cause for concern and could result in users injecting products of unknown origin.

Some professionals stated the popularity for retatrutide could be connected to the increasing cost of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, advertising, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Response and Material Removal

Based on TikTok, the service has taken down violative material and banned associated hashtags and query recommendations. The company said it was committed to keeping the platform safe and investing in strengthening compliance measures.

Online Marketplace Activities

Investigations also discovered communities with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, filled with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at home.

After moments of joining one group, a vendor posted WhatsApp details, where the majority of transactions take place. The seller sent an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, medical conditions or past usage.

Item Details and Pricing

Within these communities, posts show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for Telegram said it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering substances they can’t verify. Even if the science behind retatrutide is sound, these online versions may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But fake injections are highly dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her staff has already seen patients harmed by self-injection from unverified sources. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly said the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a company experimental product not yet authorized … may subject users to potentially significant medical dangers”.